Inpatient Update
Inpatient Update delivers short, practical reviews of new studies that matter to hospitalists—focused on what actually changes decisions on rounds tomorrow. Efficient, evidence-based, and built for the working clinician.
Inpatient Update
Episode 1: ERCP Antibiotics, Apixaban Dose in Cancer, and Early Beta-Blockers in Cirrhosis
•
Mason Turner, MD
•
Season 1
•
Episode 1
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this pilot episode of Inpatient Update, your host, Dr. Mason Turner, breaks down three clinically relevant studies that could change how you practice tomorrow on the wards:
- Pre-ERCP antibiotic prophylaxis — does it reduce post-procedure infections in biliary obstruction?
- Reduced-dose apixaban after 6 months in cancer-associated VTE — noninferior and potentially safer?
- Early initiation of beta-blockers in cirrhosis with uncomplicated ascites — early signals of benefit.
Practical take-homes, clear links to evidence, and what to tell your team on rounds.
Articles & PubMed Links
- Is Antibiotic Prophylaxis Warranted in All Patients With Biliary Obstruction Undergoing Endoscopic Retrograde Cholangiopancreatography?: A Systematic Review and Meta-Analysis
PubMed: https://pubmed.ncbi.nlm.nih.gov/40961256/ - Extended Reduced-Dose Apixaban for Cancer-Associated VTE (API-CAT)
PubMed: https://pubmed.ncbi.nlm.nih.gov/40162636/ - Efficacy and Safety of Carvedilol in Cirrhosis Patients With New-Onset Uncomplicated Ascites Without High-Risk Esophageal Varices (CARVE-AS Trial)
PubMed: https://pubmed.ncbi.nlm.nih.gov/40689908/